News and Activities
Hot Off The Press.
Press Releases
Proteocyte Welcomes Key Advisor Ed Gudaitis as Commercial Launch Gathers Momentum
Toronto, ON; July 19, 2023 - Proteocyte AI is pleased to announce the the addition of Edward Gudaitis as a Business Advisor. Ed is an experienced life sciences and pharmaceutical leader with over 28 years of senior leadership experience across multiple stages of pharmaceutical commercialization...
AIMM Publishes Key Paper Detailing Proteocyte’s Superior Oral Cancer Risk Assessment System
Toronto, ON; July 17, 2023 - Proteocyte AI is pleased to announce the publication of its latest clinical research paper by Applied Immunohistochemistry & Molecular Morphology (AIMM). The paper strongly supports the risk assessment system used as part of STRATICYTE™, Proteocyte's first oral...
Proteocyte Welcomes Life Sciences Innovator Mike Cloutier in Advisory Role
Toronto, ON; Februrary 1, 2023 - In its latest addition to a growing talent pool, Proteocyte AI is pleased to announce the arrival of Mike Cloutier as a Senior Advisor, effective February 1, 2023. Proteocyte AI is a company dedicated to producing a range of technological solutions that predict a...
Key Patent Awarded as Straticyte Progresses Towards Full Commercial Release
Toronto, ON; January 9, 2023 - Proteocyte AI, a company dedicated to producing a range of technological solutions that predict a patient's risk of developing oral cancer, has just been awarded an important patent in the United States for the first oral dysplasia prognostic test of its kind,...